期刊文献+

高通量全外显子测序诊断2A型肢带型肌营养不良1例 被引量:1

Diagnosis of a case with type 2A of limb-girdle muscular dystrophy by high-throughput sequencing
下载PDF
导出
摘要 目的对1例患有肌营养不良的中国籍汉族男孩进行临床分子诊断。方法运用高通量测序技术对1例已排除杜氏/贝氏进行性肌营养不良(DMD/BMD)的患儿进行外周血有核细胞基因全外显子组测序(WES),并使用Sanger测序对WES发现的基因相关突变进行验证。结果 WES发现钙蛋白酶3基因(CAPN3)存在复合杂合突变,其中3号外显子区域发现1个杂合的无义突变c.439C>T,p.Arg147*,而13号外显子存在1个杂合的错义突变c.1621C>T,p.Arg541Trp。结论借助高通量DNA测序技术,该患者最终被诊断为2A型肢带型肌营养不良(LGMD)。 Objective To perform the clinical molecular diagnosis in a Chinese Han boy with musculardystrophy. Methods This boy had been diagnosed to exclude Duchenne and Becker muscular dystrophy(DMD/BMD). The whole exome sequencing(WES) was performed for his peripheral blood genomic DNA,and therelevant mutations identified by WES were verified by Sanger sequencing. Results WES results revealed thatcalpin 3 gene(CAPN3) existed 2 compound heterozygous mutations. One is a heterozygous nonsense mutationc.439C>T,p.Arg147* in exon 3,while exon 13 had another heterozygous missense mutation c.1621C>T,p. Arg541Trp. Conclusions By high-throughput sequencing,the patient is eventually diagnosed as type 2A oflimb-girdle muscular dystrophy(LGMD).
作者 胡娟 申春梅 王剑 李牛 HU Juan;SHEN Chunmei;WANG Jian;LI Niu(Department of Clinical Laboratory,the Fifth People's Hospital of Shanghai,Fudan University,Shanghai 200240,China;Institute of Pediatric Translational Medicine,Shanghai Children's Medical Center,Shanghai Jiaotong University School of Medicine,Shanghai 200127,China)
出处 《检验医学》 CAS 2016年第12期1093-1096,共4页 Laboratory Medicine
关键词 肢带型肌营养不良症 钙蛋白酶3 全外显子测序 基因突变 Limb-girdle muscular dystrophy Calpin 3 Whole exome sequencing Gene mutation
  • 相关文献

参考文献5

二级参考文献22

  • 1任守臣,焉传祝,李茂绪,刘淑萍,吴金玲,赵玉英,李伟,李大年.肢带型肌营养不良和Miyoshi肌病dysferlin表达分析[J].中华医学杂志,2007,87(21):1486-1490. 被引量:6
  • 2Hu J, Higuchi I, Yoshida Y, et al. Expression of midkine in regenerating skeletal muscle fibers and cultured myoblasts of human skeletal muscle. Eur Neurol, 2002,47: 20-25.
  • 3Brown SC, Muntoni F, Sewry CA. Non-sarcolemmal muscular dystrophies. Brain Pathol, 2001, 11 : 193-205.
  • 4Keira Y, Noguchi S, Minami N, et al. Localization of calpain 3 in human skeletal muscle and its alteration in limb-girdle muscular dystrophy 2A muscle. J Biochem, 2003, 133 : 659-664.
  • 5Kramerova I, Beckmann JS, Spencer MJ. Molecular and cellular basis of calpainopathy ( limb girdle muscular dystrophy type 2A). Biochim Biophys Acta, 2007, 1772: 128-144.
  • 6Baghdiguian S, Richard I, Martin M, et al. Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle. J Mol Med, 2001,79: 254-261.
  • 7Kirsehner J, Bonnemann CG. The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries. Arch Neurol, 2004, 61 : 189-199.
  • 8Anderson LV, Harrison RM, Pogue R, et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy ( primary dysferlinopathies). Neuromuscul Disord, 2000, 10: 553-559.
  • 9Chrobakova T, Hermanova M, Kroupova I, et al. Mutations in Czech LGMD2A patients revealed by analysis of calpain3 mRNA and their phenotypic outcome. Neuromuscul Disord, 2004, 14: 659-665.
  • 10Godfrey C, Escolar D, Brockington M, et al. Fukutin gene mutations in steroid-responsive limb girdle muscular dystrophy. Ann Neurol, 2006, 60: 603-610.

共引文献10

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部